News

DEME's Remarkable Growth: Q3 2025 Trading Results Unveiled

DEME's Remarkable Growth: Q3 2025 Trading Results Unveiled

Impressive Quarterly Update for DEME in 2025

The latest trading update for DEME reveals a stellar performance in the third quarter of 2025, marking yet another significant milestone for the company. With an increase in turnover that has surpassed 3 billion euros, DEME is witnessing a robust growth trajectory compared to the previous year. This impressive achievement not only reflects the company's operational efficiency but also highlights its strategic positioning in the market.

Turnover Growth and Order Book Expansion

For the first nine months of 2025, DEME has reported a turnover increase of 3% year-over-year. This growth is further underscored by a strong order book totaling 7.5 billion euros, compared to 7.1 billion euros in the same period last year. The robust order book showcases DEME's successful engagements and projects, indicating a strong demand for its services.

Management's Outlook for 2025

Management has reiterated its optimistic stance, expecting that the total turnover for the full year will meet or even exceed the results of 2024. This forward-looking attitude comes in tandem with a projected year-over-year improvement in EBITDA. DEME anticipates the EBITDA margin to fall within a promising range of 20% to 22%, a testament to its effective cost management and operational strategies.

Innovative Developments with Norse Wind

In terms of fleet expansion, DEME has made a significant leap by taking delivery of its new offshore installation vessel, Norse Wind, which was completed on schedule in October. This vessel is set to begin operations in the first half of 2026, positioning DEME to capitalize on upcoming opportunities in the offshore sector. The acquisition of Norse Wind is a clear indicator of the company’s commitment to enhancing its capabilities and leading in the offshore renewable energy market.

Commitment to Excellence

DEME's sustained success and innovative advancements position it as a prominent player within its sector. The company continues to adapt and evolve, ensuring that it remains at the forefront of the industry by leveraging its expertise and executing large-scale projects effectively. The developments from this quarter not only highlight its current successes but also its strategic vision for future growth.

Frequently Asked Questions

What were the main highlights from DEME's Q3 2025 update?

The key highlights include a turnover surpassing 3 billion euros, an expanded order book of 7.5 billion euros, and a new offshore vessel set to commence operations.

What does the future hold for DEME's turnover?

Management expects the full-year turnover to at least match that of 2024, reflecting confidence in ongoing operations and project scopes.

What are the EBITDA expectations for DEME in 2025?

DEME forecasts a strong improvement in year-over-year EBITDA with margins projected between 20% and 22%.

What is the significance of the Norse Wind vessel?

The Norse Wind vessel will enhance DEME’s offshore installation capabilities, expected to operate in the first half of 2026, reflecting its commitment to renewable energy development.

How has DEME demonstrated its growth in the market?

DEME's growth is showcased through its increased turnover, expanded order book, and strategic investments in modern vessels, indicating a strong position in the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 17

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 36

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 30

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 15

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
GeeLark's Tech Leap: Expanding Cloud Phone Functions

Updated Category News Views 3

GeeLark's New Frontier GeeLark is kicking up some dust in the tech space by tooling up its cloud phone workflows with an arsenal of new supports: API, CLI, and MCP. This isn't just some minor patch, folks. It's a bold move, and for those in the quicksand of digital operations, a game-changer. You know how much of a drag it is repeating the same setup steps over and over?...

Continue Reading

Top 5 Most Recently Viewed Articles

Chipotle Launches Exclusive Rewards Program for College Students

Updated Category News Views 182

Chipotle Introduces Chipotle U Rewards Chipotle Mexican Grill is excited to announce a innovative new loyalty program called Chipotle U Rewards. This initiative is tailor-made to enhance the college experience for students. As a pioneer in establishing a rewards system specifically for college-goers, Chipotle aims to recognize and celebrate their milestones throughout...

Continue Reading
Investors Invited to Join Outset Medical, Inc. Class Action Suit

Updated Category News Views 97

Join the Outset Medical, Inc. Class Action Lawsuit Investors have a unique opportunity to participate in a class action lawsuit involving Outset Medical, Inc. (NASDAQ: OM). Rosen Law Firm, a reputable law firm specializing in investor rights, is encouraging purchasers of Outset Medical's securities during the relevant period to step forward. If you acquired shares between...

Continue Reading
Kirkland's Financial Results Report Set for June 2025 Release

Updated Category News Views 147

Kirkland's to Release Q1 Fiscal 2025 Financial Results Kirkland's, Inc. (Nasdaq: KIRK), a leading name in home décor and furnishings, has announced that its financial results for the first quarter of 2025 will be published before the market opens on an upcoming Tuesday in June. This anticipated announcement marks another step in Kirkland's commitment to transparency and...

Continue Reading
Upper Airway Stimulation Market Sees Promising Growth Trends

Updated Category News Views 115

Overview of Upper Airway Stimulation Market Trends The global upper airway stimulation market is poised for substantial growth in the coming years. Driving this trend is the increasing demand for innovative treatments aimed at effectively managing sleep apnea, particularly obstructive sleep apnea (OSA). With a projected market valuation of US$ 2,050.6 million by 2034,...

Continue Reading
CleanSpark Surpasses 10,000 Bitcoin Milestone in Treasury

Updated Category News Views 177

CleanSpark Achieves a Historic Milestone with Over 10,000 Bitcoin CleanSpark Inc. (NASDAQ: CLSK), recognized as America’s Bitcoin Miner®, has reached an impressive achievement by holding more than 10,000 Bitcoin in its treasury. This remarkable milestone represents not just a number, but the culmination of the company’s dedicated mining efforts within the United...

Continue Reading